CMC Scientist

  • Regular/Permanent
  • USA / Texas
  • In Office

Welcome to Orano Med

Orano Med is at the forefront of research in nuclear medicine and is developing new therapies against cancer. Based on its unique expertise in the production of lead-212 (Pb-212) and radiolabeling technologies, Orano Med is developing innovative radioligand therapies which consist of selectively destroying cancer cells while limiting the impact on surrounding healthy cells.
With a solid portfolio of molecules in development capable of targeting various forms of cancer, and a reliable supply chain for Pb-212, Orano Med aims to become a leader in targeted alpha therapies, in particular for patients with currently unmet medical needs.

Job description

Orano Med Theranostics

 

Orano Med is seeking a detail-oriented CMC Scientist

 

We are seeking a highly motivated CMC Scientist with expertise in radiopharmaceutical development to join our CMC team. The successful candidate will design, execute, and analyze studies and create reports for R&D CMC to support the development of novel radiopharmaceutical compounds. This role offers an opportunity to contribute to groundbreaking therapies and collaborate with cross-functional teams to advance our pipeline toward clinical trials.

 

Key Responsibilities

  • Design, conduct and optimize R&D studies to characterize radiopharmaceutical compounds.
  • Analyze, interpret and troubleshoot complex datasets.
  • Prepare summary reports to support tech transfer and regulatory filings.
  • Review and further develop & refine existing processes.
  • Collaborate with cross-functional teams review protocols, batch records, formulation records, and other related documents.
  • Maintain accurate records of experiments and ensure data integrity in accordance with company policies.
  • Stay current with advancements in radiopharmaceutical science and contribute to the development of innovative research strategies.
    Other duties, as needed.

Orano strives to provide a total compensation package that brings value to our employees. We also offer highly competitive health and wellness programs, 401(k) contributions, and industry leading paid time off.

 

Our Full-Time Benefits

  • Competitive compensation 
  • Health, Dental, and Vision insurance – with generous employer contributions 
  • 401(k) with employer matching and contribution amounts 
  • Life insurance and Short- and Long-Term Disability insurance provided by the company  
  • Generous Paid Time Off and holiday schedules 
  • Numerous Training and Development opportunities 
  • and more…   

Ideal qualifications

Education & Experience:

All candidates must meet the following minimum requirements in order to be considered for this opportunity. Candidates who exceed minimum qualifications may be considered for a higher-level position.

 

Minimum Qualifications:

  • Ph.D. in biological sciences, or related field
  • 3+ years of demonstrated research experience

 

Required Skills & Competencies:

  • Excellent analytical ability and problem solving/problem resolution skills
  • Desire to work with radioisotopes
  • Excellent written and verbal communication skills with meticulous attention to detail.
  • Ability to manage multiple projects and prioritize workload effectively.
  • Strong interpersonal skills and ability to work collaboratively in a team-oriented environment

 

Preferred Skills & Competencies:

Experience with radiopharmaceuticals


CMC Scientist

Ref: 2026-22631

Regular/Permanent

Plano

Orano Med LLC - Plano TX

Orano Med is at the forefront of research in nuclear medicine and is developing new therapies against cancer. Based on its unique expertise in the production of lead-212 (Pb-212) and radiolabeling technologies, Orano Med is developing innovative radioligand therapies which consist of selectively destroying cancer cells while limiting the impact on surrounding healthy cells. With a solid portfolio of molecules in development capable of targeting various forms of cancer, and a reliable supply chain for Pb-212, Orano Med aims to become a leader in targeted alpha therapies, in particular for patients with currently unmet medical needs.

Find out more about Orano Med
By clicking “I accept Cookies”, you agree with the cookies use to enhance site navigation, analyze site usage and compile statistics. To get more information, please read our Cookies Policy in the Legal Notice